healio.com
A regimen of sofosbuvir/velpatasvir with ribavirin was effective among patients with refractory chronic hepatitis C virus with liver cirrhosis and chronic kidney disease, according to data presented at The Liver Meeting.
Researchers in China investigated the safety and efficacy of a 12-week regimen of sofosbuvir/velpatasvir with ribavirin among 65 patients (mean age, 52.3 years; 77% men) with refractory chronic HCV, liver cirrhosis and chronic kidney disease (CKD). The dosage of ribavirin for ea…
over 1 year ago
healio.com
Use of directly observed therapy was successful even at extended intervals when treating hepatitis C virus infection among people who inject drugs, according to research presented at The Liver Meeting.
Researchers in Vienna compared 239 people who inject drugs (PWIDs) on opioid agonist therapy who started directly observed therapy (DOT) with direct-acting antivirals during the COVID-19 pandemic (March 2020-October 2022) vs. a control group of 441 PWIDs receiving DOT before the pandemic (Septembe…
over 1 year ago
Media DatabaseFind the right journalists
Online NewsroomShape your own narrative
Press Release CreatorCreate and send press releases
Media MonitoringTrack every single online mention
Media Pitching ToolContact recommendations & stats
PR ReportsShowcase the impact of your work
PR CRMManage contacts in easy way
AI PR SoftwareUse AI to save time on your workflow
Social Media ListeningGet a full overview of your brand's presence